Circulation:MG53上调PPAR -α诱导糖尿病心肌病产生,提示其可作为糖尿病心肌病的治疗目标

2015-02-04 MedSci MedSci原创

研究显示MG53在小鼠中高标达,会产生肥胖,全身胰岛素抵抗,血脂异常以及高血糖症;而MG53确实可以抑制高脂肪饮食诱导产生的代谢紊乱,包括肥胖,脂质异常和高血糖症。MG53最初显示其在膜修复中有着重要作用。本研究显示MG53可以作为E3连接酶胰岛素受体和胰岛素受体底物1泛素依赖性讲解,从而导致胰岛素抵抗和代谢紊乱。然而MG53在心肌葡萄糖代谢和脂质代谢中也具有调节作用仍旧未知。中国北京大学曹春梅、

研究显示MG53在小鼠中高标达,会产生肥胖,全身胰岛素抵抗,血脂异常以及高血糖症;而MG53确实可以抑制高脂肪饮食诱导产生的代谢紊乱,包括肥胖,脂质异常和高血糖症。MG53最初显示其在膜修复中有着重要作用。本研究显示MG53可以作为E3连接酶胰岛素受体和胰岛素受体底物1泛素依赖性讲解,从而导致胰岛素抵抗和代谢紊乱。然而MG53在心肌葡萄糖代谢和脂质代谢中也具有调节作用仍旧未知。中国北京大学曹春梅、肖瑞平等人MG53在心肌中的作用,研究了其对糖尿病心肌病的诱导机制,研究成果发表在1月份Circulation期刊上。
 
背景:
糖尿病心肌病,会导致超过50%的糖尿病患者死亡,具有以下特色:心肌脂质沉积肌肥大,心肌纤维化以及心肌功能失调。对糖尿病心肌病机制了解目前仍知之甚少。目前研究显示:E3泛素连接酶MG53(MG53, or TRIM72)是全身胰岛素抵抗和代谢紊乱的主要病因。虽然MG53在心肌中广泛表达,其引发心肌代谢紊乱的生物和病理机制仍然难以捉摸。
 
方法和结果:MG53心脏特异性转基因表达诱导小鼠糖尿病性心肌病发生。MG53转基因鼠20周后出现严重的糖尿病性心肌病,通过胰岛素抵抗,葡萄糖摄取功能受损,脂质集聚增加,心肌肥大,心肌纤维化,心肌功能失调检测病情。MG53高表达通过使胰岛素受体和其底物1的失调从而导致胰岛素抵抗的产生。更重要的是,研究检测了MG53新的角色:它可以上调过氧化物酶体增生物激活受体α(PPAR-α)及其目标基因,从而导致脂质沉积和脂毒性,最终诱导产生糖尿病性心肌病。
 
结局:研究提示心肌MG53通过双重机制(上调PPAR-α和损害胰岛素信号)诱导糖尿病性心肌病产生。这些结果并不单单显示了MG53调节心肌PPAR-α和脂质代谢的新功能,而且也强调了MG53对于糖尿病相关的心肌病来说,可以作为一种重要的治疗目标。

原始出处:
 
Liu F, Song R, Feng Y, Guo J, Chen Y, Zhang Y, Chen T, Wang Y, Huang Y, Li CY, Cao C, Zhang Y, Hu X, Xiao RP. Upregulation of MG53 Induces Diabetic Cardiomyopathy via Transcriptional Activation of PPAR-alpha. Circulation. 2015.

本文是MedSci编译,欢迎转载,转载请注明出处,非常感谢!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=20390, encodeId=497720390c2, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16699, encodeId=c880166997f, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:21:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16256, encodeId=f1a71625628, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:03:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16199, encodeId=0a7c1619901, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:54:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15272, encodeId=1ec7152e2fa, content=好!谢谢!学习了!长知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:28:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622208, encodeId=eff51622208bf, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Feb 06 01:52:00 CST 2015, time=2015-02-06, status=1, ipAttribution=)]
    2015-04-11 x35042875

    AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=20390, encodeId=497720390c2, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16699, encodeId=c880166997f, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:21:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16256, encodeId=f1a71625628, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:03:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16199, encodeId=0a7c1619901, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:54:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15272, encodeId=1ec7152e2fa, content=好!谢谢!学习了!长知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:28:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622208, encodeId=eff51622208bf, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Feb 06 01:52:00 CST 2015, time=2015-02-06, status=1, ipAttribution=)]
    2015-02-22 orthoW

    不错的文章,学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=20390, encodeId=497720390c2, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16699, encodeId=c880166997f, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:21:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16256, encodeId=f1a71625628, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:03:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16199, encodeId=0a7c1619901, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:54:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15272, encodeId=1ec7152e2fa, content=好!谢谢!学习了!长知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:28:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622208, encodeId=eff51622208bf, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Feb 06 01:52:00 CST 2015, time=2015-02-06, status=1, ipAttribution=)]
    2015-02-17 chinayinhan

    已阅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=20390, encodeId=497720390c2, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16699, encodeId=c880166997f, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:21:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16256, encodeId=f1a71625628, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:03:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16199, encodeId=0a7c1619901, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:54:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15272, encodeId=1ec7152e2fa, content=好!谢谢!学习了!长知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:28:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622208, encodeId=eff51622208bf, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Feb 06 01:52:00 CST 2015, time=2015-02-06, status=1, ipAttribution=)]
    2015-02-17 chinayinhan

    已阅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=20390, encodeId=497720390c2, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16699, encodeId=c880166997f, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:21:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16256, encodeId=f1a71625628, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:03:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16199, encodeId=0a7c1619901, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:54:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15272, encodeId=1ec7152e2fa, content=好!谢谢!学习了!长知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:28:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622208, encodeId=eff51622208bf, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Feb 06 01:52:00 CST 2015, time=2015-02-06, status=1, ipAttribution=)]
    2015-02-08 xjtumed10

    好!谢谢!学习了!长知识!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=20390, encodeId=497720390c2, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:47:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16699, encodeId=c880166997f, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=165, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Sun Feb 22 09:21:00 CST 2015, time=2015-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16256, encodeId=f1a71625628, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 01:03:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16199, encodeId=0a7c1619901, content=已阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Tue Feb 17 00:54:00 CST 2015, time=2015-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15272, encodeId=1ec7152e2fa, content=好!谢谢!学习了!长知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Sun Feb 08 10:28:00 CST 2015, time=2015-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622208, encodeId=eff51622208bf, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Feb 06 01:52:00 CST 2015, time=2015-02-06, status=1, ipAttribution=)]

相关资讯

Lancet子刊:预防糖尿病,开始运动吧!

美国亚特兰大退伍军人医疗中心的Jackson教授带领的研究小组开展了一项名为“MOVE!”的观察性研究,该项目是全美国最大的生活方式改变研究,旨在观察生活方式的改变是否能够促进健康,并在临床环境下验证参与该项目是否能够降低糖尿病的发生率。 研究从退伍军人医疗中心(VA)数据库中选取了2005年至2012年间超重以及肥胖的患者的数据,患者均患有体重相关的疾病,且曾在门诊进行过3年以上的治疗。对获取

癌症还是糖尿病:机体的选择

一项最新的研究发现,癌症治疗之后患者对于糖尿病药物治疗的效果下降了。 这一结果说明糖尿病治疗的效果的下降可能会影响患者的存活,而且也部分解释了为什么在癌症治疗后使用糖尿病药物的患者要比高血糖的患者死亡率更高。研究作者Marjolein MJ Zanders博士认为。   Zanders博士认为,患者与医师在癌症治疗后对糖尿病药物的使用上要十分慎重。患者的健康受到多方面因素的影响,因

Endocrinology:研究人员发现预防I型糖尿病的方法

由圣路易斯大学药理和生理科学主席托马斯•伯里斯博士报告的,一项发表在内分泌学上的新研究显示,他的团队在动物模型上已经找到了一种方法来防止I型糖尿病。 I型糖尿病是一种慢性自身免疫性疾病,当人体的免疫系统破坏胰岛素产生的胰腺β细胞时会导致I型糖尿病,表观为胰岛素缺乏和高血糖。目前治疗I型糖尿病关注点在通过胰岛素治疗控制血糖,但整个一生必须继续这种治疗。 伯里斯和他的研究小组专注研究阻止因β细胞损

Cancer Prev Res:二甲双胍可能还能降低糖尿病患者的肺癌风险

最新研究指出,对于不吸烟的糖尿病患者,降糖药二甲双胍的作用不仅能够控制血糖,还能降低肺癌的患病率。研究结果发表在最新一期美国癌症研究协会旗下的Cancer Prevention Research杂志上。该项研究由加利福尼亚洲奥克兰市Kaiser Permanente研究部科学家Lori Sakoda博士主持。“一些实验室研究和观察性研究提示,二甲双胍可能具有预防癌症的作用。然而,” Lori Sa

预防糖尿病从吃天然食物开始

"来自动物实验与临床观察诊断的大量结果证明:食用高糖的加工类食品会增加患2型糖尿病的风险。"一篇1月29日刊登在Mayo Clinic Proceedings杂志的综述类文章总结道。 "这篇综述第一次系统地提出了即使在保持卡路里摄入量不变的前提下,高糖食物更加容易引起糖尿病与相关症状以及过早死亡。"文章第一作者ames J DiNicolantonio博士说到。"因此,通过将糖摄入量,尤其是果

点评:继续寻找2型糖尿病的基因是否有价值?

2型糖尿病是一种高度异质性的疾病,在复杂的基因背景下,营养物质过多摄入导致体内糖脂代谢异常,引起疾病发生。因此,遗传和环境是2型糖尿病发生的两大重要方面。正方Mark McCarthy和反方Mike Lean正是从这两个方面来看待目前关于2型糖尿病的研究。在遗传学方面,正如Mark McCarthy所说,通过GWAS研究和一些表观遗传学的研究从基础研究的角度在一定程度上揭示了基因在2型糖尿病发生中